SPECT-CT Imaging of Dog Spontaneous Diffuse Large B-Cell Lymphoma Targeting CD22 for the Implementation of a Relevant Preclinical Model for Human

SPECT-CT Imaging of Dog Spontaneous Diffuse Large B-Cell Lymphoma Targeting CD22 for the Implementation of a Relevant Preclinical Model for Human

Antibodies directed against CD22 have been used in radioimmunotherapy (RIT) clinical trials to treat patients with diffuse large B-cell lymphoma (DLBCL) with promising results. However, relevant preclinical models are needed to facilitate the evaluation and optimization of new protocols. Spontaneous...

Full description

Bibliographic Details
Main Authors: Floriane Etienne, Maxime Berthaud, Frédérique Nguyen, Karine Bernardeau, Catherine Maurel, Caroline Bodet-Milin, Maya Diab, Jérôme Abadie, Valérie Gouilleux-Gruart, Aurélien Vidal, Mickaël Bourgeois, Nicolas Chouin, Catherine Ibisch, François Davodeau
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Oncology
Subjects:
comparative oncology
dog
diffuse large B-cell lymphoma
monoclonal antibody
SPECT-CT imaging
CD22
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00020/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.00020/full

Similar Items